Esomeprazole Magnesium Capsule, Delayed Release
Product Images NDC 82804-078

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 82804-078). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (B201c94c 128a 4ae1 86a1 057c4c895839 01)

Chemical structure diagram of esomeprazole magnesium, showing the molecular arrangement including methoxy and methyl groups, sulfoxide linkage, and magnesium ion complexed with three water molecules.*

FDA Label Image

Figure 2: Maintenance Of Healing Rates By Month (study 177) (B201c94c 128a 4ae1 86a1 057c4c895839 02)

A line graph showing the percentage maintained over a 6-month period for esomeprazole magnesium delayed-release capsules 40 mg and a placebo group. The graph includes data from four groups with varying sample sizes (N=91 to N=98), illustrating the sustained effect of the esomeprazole magnesium capsules compared to placebo over time.*

FDA Label Image

Figure 3: Maintenance Of Healing Rates By Month (study 178) (B201c94c 128a 4ae1 86a1 057c4c895839 03)

A line graph showing the percent maintained over a 6-month period for esomeprazole magnesium delayed-release capsules at doses of 10 mg, 20 mg, and 40 mg compared to placebo. The y-axis shows percent maintained from 0 to 100%, and the x-axis shows time in months from 0 to 6 months. The 40 mg dose maintains near 100% over 6 months, while lower doses and placebo show decreased maintenance over time.*

FDA Label Image

Figure 4: Percent Of Patients Symptom-free Of Heartburn By Day (study 225) Figure (B201c94c 128a 4ae1 86a1 057c4c895839 04)

Line graph showing the percentage of patients symptom-free over 28 diary days, comparing esomeprazole magnesium delayed-release capsules at 40 mg and 20 mg doses to a placebo group. The y-axis represents the percent of patients symptom-free, and the x-axis represents diary days from 0 to 28.*

FDA Label Image

Image (B201c94c 128a 4ae1 86a1 057c4c895839 05)

A line graph depicts the percentage of patients symptom-free over 28 days (Diary Day) for three groups: Esomeprazole Magnesium Delayed-Release Capsules 40 mg, 20 mg, and placebo. The y-axis ranges from 0 to 100 percent. Both esomeprazole groups show increasing symptom-free percentages over time, higher than placebo.*

FDA Label Image

82804-078-30 (B201c94c 128a 4ae1 86a1 057c4c895839 07)

Label for Esomeprazole Magnesium 40 mg delayed-release capsules, #30 count, from Proficient Rx LP. The label notes the active ingredient amount per capsule and includes manufacturer information (Graviti Pharmaceuticals Pvt. Ltd., Telangana, India). Storage instructions and a barcode are also visible. The label includes multiple identifiers and QR codes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.